MedTrace Logo

Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and Coronary stEnt (OAC-ALONE) Study

NCT01962545 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 690

Last updated 2018-06-11

No results posted yet for this study

Summary

The purpose of the study is to evaluate non-inferiority of oral anticoagulant (OAC) monotherapy to OAC plus single antiplatelet therapy (APT) in patients with atrial fibrillation (AF) and prior (\>12 months) coronary stenting.

Conditions

Interventions

DRUG

OAC alone

Single APT with either aspirin or clopidogrel is discontinued in this arm.

Sponsors & Collaborators

  • Research Institute for Production Development

    collaborator UNKNOWN

  • Daiichi Sankyo Co., Ltd.

    collaborator INDUSTRY

  • Satoshi Shizuta

    lead OTHER

Principal Investigators

  • Takeshi Kimura, M.D. · Kyoto University, Graduate School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-05
Primary Completion
2017-05-18
Completion
2018-05-18

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01962545 on ClinicalTrials.gov